ginseng-douchi-limits-weight-gain-and-improves-metabolic-profiles-in-obese-mice
Ginseng-Douchi Limits Weight Gain and Improves Metabolic Profiles in Obese Mice

Ginseng-Douchi Limits Weight Gain and Improves Metabolic Profiles in Obese Mice

A fermented dietary formulation combining ginseng roots and soybeans significantly restrains weight gain, reduces visceral adiposity, and mitigates metabolic dysfunction in obese male mice, according to an investigation published in Frontiers in Nutrition. Developed by researchers at the Heilongjiang Academy of Chinese Medicine Sciences, the functional product, termed Ginseng-Douchi or SC, utilizes microbial fermentation mediated by Bacillus subtilis subsp. subtilis. By administering this preparation across graduated daily doses over an eight-week intervention period, the investigators found that high-dose treatment constrained high-fat diet-induced weight accumulation to a degree comparable to the pharmaceutical anti-obesity drug orlistat. Beyond monitoring body weight, the team conducted histological, biochemical, and metagenomic analyses to characterize how the formulation impacts white and brown adipose depots, hepatic steatosis, circulating inflammatory cytokines, intestinal mucosal integrity, and the taxonomic composition of the gut microbiota.

To establish diet-induced metabolic dysfunction, the authors maintained sixty specific pathogen-free male C57BL/6 mice aged six to eight weeks on a high-fat diet providing sixty percent of energy from fat, alongside a normal maintenance chow control group. Following ten weeks of dietary preconditioning, during which high-fat fed mice achieved a body mass roughly twenty percent greater than normal controls, the animals were randomized into six cohorts of ten mice each. These groups comprised normal diet controls receiving vehicle saline, high-fat diet model mice receiving saline, an active drug reference cohort administered thirty milligrams per kilogram per day of orlistat, and three intervention groups receiving low, medium, or high doses of Ginseng-Douchi at 1.25, 2.5, and 5.0 grams per kilogram daily. The human-equivalent dosing scheme was normalized to body surface area based on a typical human daily intake of forty grams of natto. Feed intake records confirmed that body mass differences were not secondary to reduced caloric consumption.

Following eight weeks of intragastric intervention, mice in the untreated high-fat diet group reached a terminal body weight of 44.14 ± 1.82 grams, whereas normal controls averaged 29.47 ± 0.70 grams. Supplementation with high-dose Ginseng-Douchi substantially suppressed this weight gain, limiting final mass to 35.74 ± 1.17 grams, an outcome statistically comparable to the 35.36 ± 0.98 grams observed under orlistat treatment. Parallel reductions occurred in body mass index and Lee index values: high-fat feeding elevated these indices to 4.97 ± 0.11 and 375.00 ± 1.86, while high-dose intervention lowered them to 3.92 ± 0.07 and 345.00 ± 1.19. Anatomical dissection demonstrated that perirenal adipose depot mass fell from 1.25 ± 0.05 grams in model mice to 0.72 ± 0.02 grams in the high-dose group, while epididymal fat declined from 2.29 ± 0.12 grams to 1.66 ± 0.07 grams, contracting the total visceral fat index from 8.04 ± 0.18 percent to 6.69 ± 0.21 percent. Histopathological examination of epididymal adipose tissue revealed reduced adipocyte hypertrophy, decreasing lesion severity scores from 3.80 ± 0.20 to 2.40 ± 0.25.

Interscapular brown adipose tissue, an essential driver of thermogenesis and metabolic energy expenditure, exhibited notable morphological and biochemical recovery following Ginseng-Douchi administration. Histological staining showed that chronic high-fat intake induced severe brown adipose whitening, characterized by extensive lipid droplet fusion into large unilocular vacuoles and an increased pathological score of 4.00 ± 0.00 compared with 3.00 ± 0.00 in normal controls. High-dose intervention reversed this morphological deterioration, restoring multilocular lipid droplet distribution and dropping the pathological score to 0.60 ± 0.24. Immunohistochemical assessment showed that the area fraction of uncoupling protein 1, which declined to 18.56 ± 1.97 percent in untreated obese mice from 28.14 ± 4.02 percent in controls, rose to 45.23 ± 4.29 percent in the high-dose cohort. Molecular quantification revealed a decoupling between transcript and protein levels: high-fat feeding triggered a compensatory surge in Ucp1 transcript levels to 7.879 ± 0.405-fold despite depressed protein concentration at 2031 ± 51.62 picograms per milliliter, whereas high-dose intervention restored protein abundance to 2916 ± 47.4 picograms per milliliter while lowering transcript levels to 0.564 ± 0.021-fold.

Impairments in whole-body glycemic control and peripheral insulin sensitivity were assessed through dynamic physiological tolerance testing conducted at the conclusion of the treatment regimen. During the oral glucose tolerance test, mice in the untreated model group displayed prolonged hyperglycemia, generating an area under the curve of 1403 ± 69.47 millimoles per liter multiplied by minutes compared with 759.2 ± 24.28 millimoles per liter multiplied by minutes in normal controls. High-dose Ginseng-Douchi yielded the strongest glycemic improvement among the botanical cohorts, reducing the glucose excursion area under the curve to 1183 ± 43.47 millimoles per liter multiplied by minutes, which aligned closely with the 1176 ± 43.00 millimoles per liter multiplied by minutes recorded for orlistat. Similarly, the intraperitoneal insulin tolerance test demonstrated marked enhancement of insulin-mediated glucose disposal. The insulin excursion area under the curve contracted from 786.2 ± 100.6 millimoles per liter multiplied by minutes in model mice down to 597.5 ± 40.55 millimoles per liter multiplied by minutes in the high-dose group and 624.2 ± 124.9 millimoles per liter multiplied by minutes in the medium-dose cohort, matching orlistat at 604.0 ± 55.00 millimoles per liter multiplied by minutes.

Serum biochemical analyses and hepatic profiling indicated that Ginseng-Douchi effectively counteracted high-fat diet-induced dyslipidemia and excessive hepatic lipid accumulation. Serum concentrations of total cholesterol, triglycerides, and low-density lipoprotein cholesterol in model mice increased to 7.54 ± 0.27, 1.40 ± 0.05, and 2.70 ± 0.14 millimoles per liter, respectively, but high-dose treatment reduced these values to 6.12 ± 0.12, 1.11 ± 0.04, and 2.12 ± 0.08 millimoles per liter. Circulating alanine aminotransferase and aspartate aminotransferase declined from 28.67 ± 0.84 and 62.32 ± 1.31 units per liter in obese mice to 23.46 ± 1.61 and 49.56 ± 1.42 units per liter in the high-dose cohort. Liver weight decreased from 1.62 ± 0.07 grams in model animals to 1.23 ± 0.05 grams following high-dose therapy, alongside a reduction in histopathological steatosis scoring from 3.80 ± 0.20 to 2.40 ± 0.24. Quantitative Oil Red O staining demonstrated that positive lipid droplet coverage dropped from 64.19 ± 1.80 percent to 30.31 ± 2.21 percent. Furthermore, intrahepatic triglycerides dropped from 121.7 ± 3.697 to 37.68 ± 2.095 milligrams per gram, and intrahepatic total cholesterol declined from 76.01 ± 1.04 to 26.17 ± 0.51 micromoles per gram.

Microscopic evaluation of colonic tissue demonstrated that Ginseng-Douchi supported intestinal mucosal architecture and reinforced mucus barrier defenses against dietary breakdown. Hematoxylin and eosin staining revealed that high-fat feeding provoked crypt disorganization, mucosal thinning, and extensive inflammatory infiltration, elevating the colonic pathology score from 0.40 ± 0.25 in lean controls to 3.60 ± 0.25 in model mice. High-dose intervention lowered this score to 2.60 ± 0.25 while restoring crypt structure. Alcian blue-periodic acid Schiff staining confirmed that mucin-positive coverage, which declined from 33.96 ± 1.54 percent in controls to 18.54 ± 1.65 percent in model mice, recovered to 27.87 ± 1.29 percent under high-dose supplementation. Systemic circulating lipopolysaccharide fell from 377.8 ± 4.93 picograms per milliliter in model mice to 337.6 ± 5.56 picograms per milliliter with high-dose treatment, contrasting with orlistat, which increased endotoxin to 438.8 ± 4.67 picograms per milliliter. Circulating inflammatory markers displayed concordant shifts: tumor necrosis factor-alpha and interleukin-6 dropped from 778.60 ± 31.35 and 55.19 ± 1.26 picograms per milliliter to 551.80 ± 34.24 and 37.36 ± 1.19 picograms per milliliter, while anti-inflammatory interleukin-10 increased from 34.50 ± 1.38 to 50.74 ± 1.81 picograms per milliliter.

Metagenomic sequencing of luminal colon contents demonstrated that the metabolic benefits of Ginseng-Douchi occurred without driving a broad-scale restructuring of overall gut microbial diversity. Alpha diversity analysis indicated that although high-fat feeding significantly reduced species richness according to the Chao1 index from 8,703 ± 114.10 to 7,742 ± 116.40 and increased the Simpson index from 0.65 ± 0.00 to 0.74 ± 0.01, high-dose therapy yielded values of 7,828 ± 66.34 and 0.73 ± 0.01, showing no statistically significant reversal. Principal coordinate analysis based on Bray-Curtis distance showed distinct clustering between lean and obese cohorts, while intervention samples displayed only partial coordinate shifts. At the phylum level, changes in Firmicutes and Bacteroidota abundance were not statistically significant after intervention. Instead, taxonomic discrimination revealed selective genus-level adjustments: high-dose treatment significantly suppressed the abnormal enrichment of Schaedlerella and Faecalibaculum provoked by dietary fat, while selectively enriching beneficial genera including Bifidobacterium and Dorea.

Functional annotation using the Kyoto Encyclopedia of Genes and Genomes and Carbohydrate-Active Enzymes databases provided insight into microbial metabolic shifts under high-dose intervention. While pathway-level analysis at KEGG Level 3 revealed no comprehensive global reprogramming, targeted analysis of individual gene orthologs identified distinct functional alterations. The intervention significantly suppressed microbial bile-salt hydrolase genes (cbh) and bile acid-inducible operon clusters (baiCD, baiI, baiH), which were elevated in obese mice. Furthermore, core genes essential for lipopolysaccharide lipid-A biosynthesis, including lpxA, lpxB, lpxD, and waaC, were partially restored toward normal control levels. Carbohydrate enzyme profiling revealed distinctive enrichment of glycoside hydrolase family 1, glycosyltransferase families 2 and 68, and carbohydrate-binding module 50. Fecal metabolite analyses showed directional but statistically non-significant decreasing trends across short-chain fatty acids including acetate, propionate, and butyrate, alongside shifts in bile acid profiles wherein cholic acid and beta-muricholic acid trended upward while deoxycholic acid and ursodeoxycholic acid exhibited mild contractions.

The investigators attributed these biological effects to the chemical transformation of active compounds during co-fermentation, where primary ginsenosides such as Rb1, Re, and Rg1 are deglycosylated into rare secondary ginsenosides like Rd, Rg3, and compound K, and soybean isoflavone glucosides are converted into aglycones such as daidzein and genistein. However, the authors underscored essential methodological limitations in interpreting these findings. The study was conducted exclusively in male C57BL/6 mice to eliminate cyclic estrogenic fluctuations, meaning findings cannot be directly extrapolated to females, in whom estrogen modulates adiposity patterns and gut microbiota structure. Furthermore, the observational study design did not include fecal microbiota transplantation, germ-free models, or direct quantification of colonic tight-junction proteins and whole-body indirect calorimetry. Consequently, the current experimental data establish clear phenotypic associations but cannot fully disentangle whether metabolic improvements stem directly from absorbed phytochemical metabolites or indirectly through microbiota-mediated regulatory mechanisms.

Subject of Research: Metabolic and gut microbiota effects of Ginseng-Douchi intervention in diet-induced obese mice

Article Title: Ginseng-Douchi ameliorates high-fat diet-induced obesity and metabolic disorders via gut microbiota regulation

Article References: Ren, Z., Ding, C., Sun, Y., Huo, J., Wang, W., & Dong, K. (2026). Ginseng-Douchi ameliorates high-fat diet-induced obesity and metabolic disorders via gut microbiota regulation. Frontiers in Nutrition, 13, Article 1983591. https://doi.org/10.3389/fnut.2026.1983591

Image Credits: AI Generated

DOI: 10.3389/fnut.2026.1983591

Keywords: Ginseng-Douchi, Bacillus subtilis, Panax ginseng, fermented soybean, high-fat diet, obesity intervention, visceral fat accumulation, brown adipose tissue, uncoupling protein 1, gut microbiota, metagenomic sequencing, Schaedlerella, Faecalibaculum, Bifidobacterium, intestinal barrier integrity, endotoxemia, insulin resistance, hepatic steatosis